Literature DB >> 18190933

Visual mismatch negativity highlights abnormal pre-attentive visual processing in mild cognitive impairment and Alzheimer's disease.

Andrea Tales1, Judy Haworth, Gordon Wilcock, Philip Newton, Stuart Butler.   

Abstract

Alzheimer's disease (AD) and mild cognitive impairment (MCI) are traditionally characterised in relation to abnormalities in higher-level brain function, particularly memory. However, in the study presented here we report significant abnormality in pre-attentive visual processing in both MCI and AD compared to healthy ageing. The functional integrity of the automatic change detection system was determined by measuring the visual mismatch negativity (vMMN) component of the N2 visual event-related potential (ERP) in 8 individuals with amnestic MCI, 10 individuals with AD and 10 healthy older adult controls. Compared to healthy ageing, both the MCI and AD groups displayed a significant abnormally increased vMMN over the 140-250 ms measurement epoch although such effects were not apparent over the later 250-400 ms epoch. These novel findings support the view that deficits in brain function in both AD and MCI are not exclusively high-level and indeed that abnormal output from 'low level' or pre-attentive processes (as evinced by the abnormal vMMN) is likely to contribute to the high-level processing deficits so characteristic of these clinical disorders.

Entities:  

Mesh:

Year:  2007        PMID: 18190933     DOI: 10.1016/j.neuropsychologia.2007.11.017

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  11 in total

1.  Exploring the Role of Low Level Visual Processing in Letter-Speech Sound Integration: A Visual MMN Study.

Authors:  Dries Froyen; Nienke van Atteveldt; Leo Blomert
Journal:  Front Integr Neurosci       Date:  2010-04-13

2.  Mismatch negativity latency as a biomarker of amnestic mild cognitive impairment in chinese rural elders.

Authors:  Li-Li Ji; Yuan-Yuan Zhang; Lane Zhang; Bing He; Guo-Hua Lu
Journal:  Front Aging Neurosci       Date:  2015-03-12       Impact factor: 5.750

3.  A frontal attention mechanism in the visual mismatch negativity.

Authors:  Craig Hedge; George Stothart; Jenna Todd Jones; Priscila Rojas Frías; Kristopher Lundy Magee; Jonathan C W Brooks
Journal:  Behav Brain Res       Date:  2015-07-13       Impact factor: 3.332

4.  Visual mismatch negativity in the dorsal stream is independent of concurrent visual task difficulty.

Authors:  Jan Kremláček; Miroslav Kuba; Zuzana Kubová; Jana Langrová; Jana Szanyi; František Vít; Michal Bednář
Journal:  Front Hum Neurosci       Date:  2013-07-30       Impact factor: 3.169

5.  Impairment in preattentive processing among patients with hypertension revealed by visual mismatch negativity.

Authors:  Cuiping Si; Changjie Ren; Peng Wang; Hetao Bian; Haiming Wang; Zhongrui Yan
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

Review 6.  Visual mismatch negativity: a predictive coding view.

Authors:  Gábor Stefanics; Jan Kremláček; István Czigler
Journal:  Front Hum Neurosci       Date:  2014-09-16       Impact factor: 3.169

7.  Task difficulty affects the predictive process indexed by visual mismatch negativity.

Authors:  Motohiro Kimura; Yuji Takeda
Journal:  Front Hum Neurosci       Date:  2013-06-12       Impact factor: 3.169

8.  vMMN for schematic faces: automatic detection of change in emotional expression.

Authors:  Kairi Kreegipuu; Nele Kuldkepp; Oliver Sibolt; Mai Toom; Jüri Allik; Risto Näätänen
Journal:  Front Hum Neurosci       Date:  2013-10-28       Impact factor: 3.169

9.  The mismatch negativity as an index of cognitive decline for the early detection of Alzheimer's disease.

Authors:  Manuela Ruzzoli; Cornelia Pirulli; Veronica Mazza; Carlo Miniussi; Debora Brignani
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

10.  Subjective Cognitive Impairment in 55-65-Year-Old Adults Is Associated with Negative Affective Symptoms, Neuroticism, and Poor Quality of Life.

Authors:  Amy Jenkins; Jeremy J Tree; Ian M Thornton; Andrea Tales
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.